Received Mar 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Rotator cuff injury; First administration was administered too high in the shoulder; This is a spontaneous report received from a Consumer or other non HCP. A female patient (not pregnant) received BNT162b2 (BNT162B2), in 2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious) with onset 2021, outcome "unknown", described as "First administration was administered too high in the shoulder"; ROTATOR CUFF SYNDROME (disability, medically significant) with onset 2021, outcome "recovered with sequelae", described as "Rotator cuff injury". Therapeutic measures were taken as a result of rotator cuff syndrome. Clinical information: The reporter described an event in 2021 receiving the Covid vaccine. First administration was administered too high in the shoulder and caused a rotator cuff injury. This was reported to Pfizer. Second injection produced a similar injury. Surgery was required to resolve injury in the first case and may have been needed in the second case. Happened in 2021. The patient recovered with lasting effects. The event required surgical intervention. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202600039257 Same reporter, patient, and event, different dose;